$PainReform (PRFX.US)$ 🙌🏼

$PainReform (PRFX.US)$
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
PainReform (Nasdaq: PRFX) announced partial topline data from its Phase 3 clinical trial of PRF-110 for post-surgical pain management in bunionectomy patients.
The initial analysis shows statistically significant superiority over placebo in pain reduction during the first 48 hours post-surgery.
However, data for the subsequent 24-hour period, important for the primary endpoint assessment, r...